Kevin Biglan

Eli Lilly (United States) — United States

Medicine · Health Sciences

43h-index12.1kcitations150works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(67), Neurological disorders and treatments(47), Genetic Neurodegenerative Diseases(46), Mitochondrial Function and Pathology(18), Telemedicine and Telehealth Implementation(16)

Publications147 total

Quantifying natural amyloid plaque accumulation using disease progression modeling with ADNI, BioFINDER, and LEARN datasets
Alzheimer s & Dementia·2025Open Access
PCR136 Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population
Value in Health·2025
Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study
Parkinsonism & Related Disorders·2025Open Access
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
JMIR Research Protocols·2025Open Access
Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results
Parkinsonism & Related Disorders·2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study (Preprint)
2025
Longitudinal Clinical Outcomes in Lrrk2 G2019s Non-Manifest Carriers in a Remote Nationwide Study
SSRN Electronic Journal·2025Open Access
Huntington’s disease
Elsevier eBooks·2024· 2 cited
List of Contributors
Elsevier eBooks·2024Open Access
Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
Digital Biomarkers·2023· 1 citedOpen Access
Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia
Parkinsonism & Related Disorders·2023· 14 citedOpen Access
Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
Neurology and Therapy·2022· 20 citedOpen Access
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease
Neurology Genetics·2022· 10 citedOpen Access
Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia
Journal of Parkinson s Disease·2022· 13 citedOpen Access
Epidemiology and economic burden of Lewy body dementia in the United States
Current Medical Research and Opinion·2022· 41 citedOpen Access
The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers
Journal of Pharmacology and Experimental Therapeutics·2021· 10 citedOpen Access
Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
Movement Disorders·2021· 37 citedOpen Access
Single and multiple ascending dose studies in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme
Alzheimer s & Dementia·2021· 6 citedOpen Access
Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers
Alzheimer s & Dementia·2021· 8 cited
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease
Clinical Pharmacology in Drug Development·2021· 7 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

E. Ray Dorsey(22), Ira Shoulson(10), Karl Kieburtz(8), Caroline M. Tanner(8), Martha Nance(7), David Oakes(7), Christopher A. Ross(7), Karen Marder(7), Christopher A. Beck(7), Jane S. Paulsen(6), Mark Guttman(6), Michael Bull(6), Andrew Feigin(6), William Zhu(5), Douglas R. Langbehn(5), Leigh J. Beglinger(5), Vinayak Venkataraman(5), Irene Hegeman Richard(5), Carlos Singer(5), Meredith A. Achey(5)